![]() | ![]() |
Formats:
|
||||||||||
Copyright © 2006, EMBO and Nature Publishing Group Core transcriptional regulatory circuitry in human hepatocytes 1Young Laboratory, Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA, USA 2Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA 3Biological Engineering Division, Massachusetts Institute of Technology, Cambridge, MA, USA 4Departments of Medicine and Human Genetics, University of Chicago, Chicago, IL, USA 5Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA aYoung Laboratory, Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA. Tel.: +1 617 258 5218; Fax: +1 617 258 0376; E-mail: young/at/wi.mit.edu Received November 7, 2005; Accepted February 24, 2006. This article has been cited by other articles in PMC.Abstract We mapped the transcriptional regulatory circuitry for six master regulators in human hepatocytes using chromatin immunoprecipitation and high-resolution promoter microarrays. The results show that these regulators form a highly interconnected core circuitry, and reveal the local regulatory network motifs created by regulator–gene interactions. Autoregulation was a prominent theme among these regulators. We found that hepatocyte master regulators tend to bind promoter regions combinatorially and that the number of transcription factors bound to a promoter corresponds with observed gene expression. Our studies reveal portions of the core circuitry of human hepatocytes. Keywords: autoregulation, hepatocyte, transcriptional regulation, regulatory hierarchy, chromatin immunoprecipitation Introduction The liver performs a number of complex functions essential for life including the uptake and storage of glucose, synthesis of bile acids, production of plasma proteins, and drug detoxification. These functions are carried out by hepatocytes, which comprise the bulk of the liver tissue. We and others have begun to use genome-scale approaches to determine the transcriptional regulatory circuitry of hepatocytes (Friedman et al, 2004; Odom et al, 2004; Phuc Le et al, 2005; Rubins et al, 2005; Zhang et al, 2005). These studies have been limited because they focused on a small number of regulators and used low-resolution technology that explored only a subset of proximal promoters in the mammalian genome. We mapped the promoter occupancy of six master regulators in primary human hepatocytes using chromatin immunoprecipitation (ChIPs) combined with DNA microarrays representing large (10 kb) portions of promoter regions for most annotated human genes. Our results provide a high-resolution, genome-wide overview of the core transcriptional circuitry of human hepatocytes. Results and discussion Identification of transcription factor binding sites To initiate mapping of the transcriptional regulatory circuitry of primary human hepatocytes, we selected regulators known to be critical to hepatocyte biology based on genetic experiments in mouse or human (HNF1α, HNF4α, FOXA2/HNF3β, HNF6/ONECUT1, CREB1, and USF1) (Table I, Supplementary Table S1) (Kuo et al, 1992; Pani et al, 1992; Cereghini 1996; Duncan et al, 1998; Zaret 2002; Costa et al, 2003; Montminy et al, 2004; Pajukanta et al, 2004; Lee et al, 2005). These liver-enriched transcription factors can also play important roles in other tissues (e.g. kidney and pancreatic islets) (Bell and Polonsky, 2001). We then determined promoter occupancy for these six regulators by combining ChIPs with microarrays that have high resolution and extensive promoter coverage (Materials and methods). We employed DNA microarrays that contain 60-mer oligonucleotide probes covering the region from −8 to +2 kb relative to the transcript start sites for almost 18 000 annotated human genes, which were compiled from five independent databases (Boyer et al, 2005). Most known transcription factor binding sites occur within –8/+2 kb of the transcription start site (Boyer et al 2005); this is also true for the transcription factors studied here, although some binding sites have been identified in other regions (Tronche et al, 1997; Rada-Iglesias et al, 2005). The sites occupied by transcription factors were represented by peaks of ChIP-enriched DNA that spanned neighboring probes (examples in Supplementary Figure S1). The coverage of promoter regions averaged one 60 mer for each 250 bases of sequence (Boyer et al, 2005).
Identification of transcriptional regulatory motifs We analyzed this high-resolution data using previously reported methods (Lee et al, 2002) to identify transcriptional network regulatory motifs (the simplest units of network structure), and thus to determine how these six key hepatocyte regulators contribute to autoregulatory loops, multicomponent loops, feed-forward loops, and multi-input motifs (Figure 1
Several aspects of the regulatory circuitry present among these master regulators have been noted or suggested previously. The network is highly interconnected (Figure 1A Feed-forward loops were observed for seven combinations of transcriptional regulators (Figure 1 Prevalence of autoregulation among hepatocyte regulators A remarkable feature of the portions of hepatocyte regulatory circuitry we studied here is the frequency of autoregulatory loops: five of the six regulators (83%) occupied their own promoters (Figure 1A In mammalian cells, transcription factors that have autoregulatory loops are frequently considered master regulators of tissues or key processes. These include, for example, OCT4 in embryonic stem cells (Boyer et al, 2005; Okumura-Nakanishi et al, 2005), MyoD and MyoG in muscle (Tapscott and Weintraub, 1991; Blais et al, 2005), FOXA2 in hepatocytes (Pani et al, 1992; Lee et al, 2005), and PU.1 in myeloid cells (Chen et al, 1995) (Supplementary Table S5). Importantly, most characterized mammalian transcription factors have been investigated because they play key roles in a particular tissue or cellular process. However, there are transcription factors (such as USF1) that do not occupy their own promoters (Supplementary Table S6), indicating that autoregulation is not simply a universal feature of mammalian transcription factors (Bateman, 1998). Autoregulatory motifs may be a general feature of transcription factors that play key roles in major cellular processes because they impart stability to regulatory networks (Becskei and Serrano, 2000; Brandman et al, 2005). Master regulators of hepatocytes, like those of other tissues, are known to play both positive and negative regulatory roles (Briancon et al, 2004); both positive and negative feedback loops allow systems to be resistant to noise (Becskei and Serrano, 2000; Rosenfeld et al, 2002; Brandman et al, 2005). These characteristics may be crucial for regulators that are responsible for tissue-specific programs in higher eukaryotes. Statistical enrichment of multiple binding events and correlation of promoter occupancy with gene expression Well-characterized liver promoters are often controlled combinatorially by multiple liver-enriched transcription factors (Cereghini, 1996; Krivan and Wasserman, 2001; Costa et al, 2003; Friedman et al, 2004; Phuc Le et al, 2005; Rada-Iglesias et al, 2005). This prompted us to inspect our genome-wide binding data for evidence of enrichment in combinatorial promoter occupancy. Comparison of the experimental data against randomized binding data (randomized by assuming all factors bind independently) revealed a statistically significant enrichment in the number of promoters bound by two or more transcriptional regulators. The enrichment generally increases with the number of transcriptional regulators bound (Figure 2A
It might be expected that the presence of larger numbers of liver-specific transcription factors at a promoter region would increase the probability that the associated gene was expressed. We tested this hypothesis by classifying genes by the presence or absence of transcripts in the liver (Su et al, 2004), and comparing these categories with the number of regulators bound to corresponding promoters. We found a strong correspondence between these two values (Figure 2B Conclusions We have used a systematic approach to identify the set of human promoters bound by six master regulators that are essential for proper liver development and function. The results show that these regulators form a highly interconnected core circuitry in human hepatocytes, identify the local regulatory network motifs created by regulator–gene interactions, and reveal that autoregulation is a predominant theme among liver-enriched transcription factors. The data support previous predictions that these factors co-occupy many genes to control hepatocyte gene expression, and there exists a direct correspondence between the number of regulators bound to a promoter region and the probability that a gene is expressed. This initial analysis of a portion of the regulatory circuitry in human liver should lay the foundation for future efforts to more fully elucidate the hepatic transcriptional program. Data Accession Number Data accession number at ArrayExpress is E-WMIT-9. Supplementary Material Click here to view.(2.8M, pdf) Supplementary Information 1 Click here to view.(77K, txt) Supplementary Information 2 Click here to view.(22K, txt) Supplementary Information 3 Click here to view.(199K, txt) Supplementary Information 4 Click here to view.(63K, txt) Supplementary Information 5 Click here to view.(94K, txt) Supplementary Information 6 Click here to view.(92K, txt) Acknowledgments We thank the Whitehead Center for Microarray Technology and Whitehead Bioinformatics and Research Computing; E Herbolsheimer, S Strom, and W Gordon for experimental and computational support; FC Wardle, G Gerber, and C Harbison for helpful discussions. This work was supported by NIH Grants DK68766 and DK20595 (GIB), DK070813 (DTO), DK68655, and HG002668 (RAY). RAY and DKG are consultants for Agilent Technologies. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||
Proc Natl Acad Sci U S A. 2004 Aug 31; 101(35):12986-91.
[Proc Natl Acad Sci U S A. 2004]Science. 2004 Feb 27; 303(5662):1378-81.
[Science. 2004]PLoS Genet. 2005 Aug; 1(2):e16.
[PLoS Genet. 2005]Mol Cell Biol. 2005 Aug; 25(16):7069-77.
[Mol Cell Biol. 2005]Proc Natl Acad Sci U S A. 2005 Mar 22; 102(12):4459-64.
[Proc Natl Acad Sci U S A. 2005]Nature. 1992 Jan 30; 355(6359):457-61.
[Nature. 1992]Mol Cell Biol. 1992 Feb; 12(2):552-62.
[Mol Cell Biol. 1992]FASEB J. 1996 Feb; 10(2):267-82.
[FASEB J. 1996]Science. 1998 Jul 31; 281(5377):692-5.
[Science. 1998]Nat Rev Genet. 2002 Jul; 3(7):499-512.
[Nat Rev Genet. 2002]Science. 2002 Oct 25; 298(5594):799-804.
[Science. 2002]Science. 2002 Oct 25; 298(5594):824-7.
[Science. 2002]Nat Genet. 2002 May; 31(1):64-8.
[Nat Genet. 2002]Science. 2004 Feb 27; 303(5662):1378-81.
[Science. 2004]Genome Res. 2001 Sep; 11(9):1559-66.
[Genome Res. 2001]Mol Cell Biol. 1992 Feb; 12(2):552-62.
[Mol Cell Biol. 1992]Science. 1998 Jul 31; 281(5377):692-5.
[Science. 1998]Nucleic Acids Res. 2001 Sep 1; 29(17):3495-505.
[Nucleic Acids Res. 2001]Hepatology. 2003 Dec; 38(6):1331-47.
[Hepatology. 2003]Nature. 2005 Jun 16; 435(7044):944-7.
[Nature. 2005]Bioinformatics. 2006 Feb 15; 22(4):423-9.
[Bioinformatics. 2006]Bioessays. 1998 May; 20(5):433-40.
[Bioessays. 1998]Nat Genet. 2002 May; 31(1):64-8.
[Nat Genet. 2002]Science. 2002 Oct 25; 298(5594):799-804.
[Science. 2002]Nature. 2004 Sep 2; 431(7004):99-104.
[Nature. 2004]Cell. 2005 Sep 23; 122(6):947-56.
[Cell. 2005]J Biol Chem. 2005 Feb 18; 280(7):5307-17.
[J Biol Chem. 2005]J Clin Invest. 1991 Apr; 87(4):1133-8.
[J Clin Invest. 1991]Genes Dev. 2005 Mar 1; 19(5):553-69.
[Genes Dev. 2005]Mol Cell Biol. 1992 Feb; 12(2):552-62.
[Mol Cell Biol. 1992]Nature. 2000 Jun 1; 405(6786):590-3.
[Nature. 2000]Science. 2005 Oct 21; 310(5747):496-8.
[Science. 2005]J Biol Chem. 2004 Aug 6; 279(32):33398-408.
[J Biol Chem. 2004]J Mol Biol. 2002 Nov 8; 323(5):785-93.
[J Mol Biol. 2002]FASEB J. 1996 Feb; 10(2):267-82.
[FASEB J. 1996]Genome Res. 2001 Sep; 11(9):1559-66.
[Genome Res. 2001]Hepatology. 2003 Dec; 38(6):1331-47.
[Hepatology. 2003]Proc Natl Acad Sci U S A. 2004 Aug 31; 101(35):12986-91.
[Proc Natl Acad Sci U S A. 2004]PLoS Genet. 2005 Aug; 1(2):e16.
[PLoS Genet. 2005]Proc Natl Acad Sci U S A. 2004 Apr 20; 101(16):6062-7.
[Proc Natl Acad Sci U S A. 2004]